Every treatment we track, side by side. Same information, same order, every time.
bevacizumab
Anti-VEGF therapy used in selected colorectal, lung, kidney, cervical, ovarian/glioblastoma contexts
encorafenib
BRAF inhibitor used in selected BRAF V600E colorectal cancer with cetuximab and melanoma contexts
cetuximab
EGFR inhibitor for selected colorectal and head/neck cancers
trifluridine/tipiracil
Oral chemotherapy for selected metastatic colorectal cancer and gastric cancer settings
regorafenib
Multikinase inhibitor for selected colorectal, GIST, and liver cancer contexts
panitumumab
EGFR inhibitor for selected RAS wild-type metastatic colorectal cancer